Reagents
ACUSOL OP301 遮光剂
- Composition
- ACUSOL OP301 商品化遮光剂配方，非单一化合物。
- Formulation
- 商品化遮光剂配方
- Quality standard
- 用于配制均匀、不透明的白色水体。
- Use information
- 用于水迷宫水体遮光。
Published protocol versions
- 小鼠 Morris 水迷宫空间学习与记忆测定 · 训练试次 · 水体遮光 0.5% · ACUSOL OP301；水体均匀、不透明白色。
Source version：protocols.io · vv1 · Sarah van Veen; Zsuzsanna Callaerts-Végh · This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
rTg4510 · Verified applicability · 阿尔兹海默症 (AD) 模型（研究 tau 病理、神经退变及 tau 表达抑制的阶段性影响；不适用于单独评价 Aβ 病理。；Verified applicability）Tg4-42 · Verified applicability · 阿尔兹海默症 (AD) 模型（研究Aβ4-42相关的海马神经发生改变，以及活动条件对齿状回结构和神经元生成的影响。；Verified applicability）APOE4 · Verified applicability · 阿尔兹海默症 (AD) 模型（研究APOE4对外周Aβ脑内转运、血脑屏障及认知表现的影响。；Verified applicability）App NL · Verified applicability · 阿尔兹海默症 (AD) 模型（研究App Swedish突变、Aβ寡聚体积累与认知表型之间的关系。；Verified applicability）Tg2576 转基因淀粉样蛋白模型（APP695 Swedish） · Verified applicability · 阿尔兹海默症 (AD) 模型（APP Swedish 突变过表达驱动的年龄依赖记忆减退与淀粉样斑研究（Tg2576）；Verified applicability）5xFAD 转基因模型 · Verified applicability · 阿尔兹海默症 (AD) 模型（5xFAD 转基因模型用于阿尔茨海默病相关淀粉样病理和神经退行性改变研究。；Verified applicability）J20 转基因淀粉样蛋白模型（APPSwInd，PDGFB） · Verified applicability · 阿尔兹海默症 (AD) 模型（J20（APP Swedish+Indiana 双突变，PDGFB 启动子）淀粉样病理与突触毒性研究的参考模型；适用性以 JAX 品系记录及 PMID:10818140 对照研究为限；Verified applicability）TgCRND8 转基因淀粉样蛋白模型（Swedish+Indiana，PrP） · Verified applicability · 阿尔兹海默症 (AD) 模型（早发强烈淀粉样沉积与认知损害范式的干预研究（TgCRND8）；Verified applicability）3xTg-AD 转基因模型 · Verified applicability · 阿尔兹海默症 (AD) 模型（3xTg-AD 转基因模型用于阿尔茨海默病相关淀粉样蛋白与 tau 病理研究。；Verified applicability）C57 小鼠 MCAO 线栓模型 · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（C57 小鼠短暂性 MCAO 再灌注模型用于缺血性脑损伤研究。；Verified applicability）transient middle cerebral artery occlusion C57BL/6J mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（Male C57BL/6J mice subjected to 90 min intraluminal MCAO; sham mice underwent identical surgery without filament insertion.；Verified applicability）permanent distal middle cerebral artery occlusion C57BL/6J mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（C57BL/6J小鼠永久性远端大脑中动脉阻塞后的白质修复与功能恢复研究。；Verified applicability）bilateral common carotid artery stenosis C57BL/6 mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（Bilateral common carotid artery stenosis produces chronic hypoperfusion and white-matter injury in C57BL/6 mice; it is a hypoperfusion reference model, not an acute focal MCA infarct.；Candidate (not internally validated)）asymmetric common carotid artery surgery C57BL/6J mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（Asymmetric common carotid artery surgery produces chronic white-matter infarct-related damage and cognitive/motor dysfunction; it is a hypoperfusion reference model, not acute territorial stroke.；Candidate (not internally validated)）bilateral common carotid artery stenosis C57BL/6J mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（Bilateral common carotid artery stenosis produces chronic hypoperfusion and white-matter injury in C57BL/6J mice; it is not an acute focal MCA infarct model.；Candidate (not internally validated)） - 小鼠 Morris 水迷宫空间学习与记忆测定 · 训练试次 · 水体遮光 0.5% · ACUSOL OP301；水体均匀、不透明白色。
Source version：protocols.io · vv1 · Sarah van Veen; Zsuzsanna Callaerts-Végh · This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
bilateral common carotid artery stenosis C57BL/6J mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（Bilateral common carotid artery stenosis produces chronic hypoperfusion and white-matter injury in C57BL/6J mice; it is not an acute focal MCA infarct model.；Candidate (not internally validated)）asymmetric common carotid artery surgery C57BL/6J mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（Asymmetric common carotid artery surgery produces chronic white-matter infarct-related damage and cognitive/motor dysfunction; it is a hypoperfusion reference model, not acute territorial stroke.；Candidate (not internally validated)）bilateral common carotid artery stenosis C57BL/6 mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（Bilateral common carotid artery stenosis produces chronic hypoperfusion and white-matter injury in C57BL/6 mice; it is a hypoperfusion reference model, not an acute focal MCA infarct.；Candidate (not internally validated)）permanent distal middle cerebral artery occlusion C57BL/6J mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（C57BL/6J小鼠永久性远端大脑中动脉阻塞后的白质修复与功能恢复研究。；Verified applicability）transient middle cerebral artery occlusion C57BL/6J mouse · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（Male C57BL/6J mice subjected to 90 min intraluminal MCAO; sham mice underwent identical surgery without filament insertion.；Verified applicability）C57 小鼠 MCAO 线栓模型 · Verified applicability · 大脑缺血再灌注 (MCAO) 模型（C57 小鼠短暂性 MCAO 再灌注模型用于缺血性脑损伤研究。；Verified applicability）3xTg-AD 转基因模型 · Verified applicability · 阿尔兹海默症 (AD) 模型（3xTg-AD 转基因模型用于阿尔茨海默病相关淀粉样蛋白与 tau 病理研究。；Verified applicability）TgCRND8 转基因淀粉样蛋白模型（Swedish+Indiana，PrP） · Verified applicability · 阿尔兹海默症 (AD) 模型（早发强烈淀粉样沉积与认知损害范式的干预研究（TgCRND8）；Verified applicability）J20 转基因淀粉样蛋白模型（APPSwInd，PDGFB） · Verified applicability · 阿尔兹海默症 (AD) 模型（J20（APP Swedish+Indiana 双突变，PDGFB 启动子）淀粉样病理与突触毒性研究的参考模型；适用性以 JAX 品系记录及 PMID:10818140 对照研究为限；Verified applicability）5xFAD 转基因模型 · Verified applicability · 阿尔兹海默症 (AD) 模型（5xFAD 转基因模型用于阿尔茨海默病相关淀粉样病理和神经退行性改变研究。；Verified applicability）Tg2576 转基因淀粉样蛋白模型（APP695 Swedish） · Verified applicability · 阿尔兹海默症 (AD) 模型（APP Swedish 突变过表达驱动的年龄依赖记忆减退与淀粉样斑研究（Tg2576）；Verified applicability）App NL · Verified applicability · 阿尔兹海默症 (AD) 模型（研究App Swedish突变、Aβ寡聚体积累与认知表型之间的关系。；Verified applicability）APOE4 · Verified applicability · 阿尔兹海默症 (AD) 模型（研究APOE4对外周Aβ脑内转运、血脑屏障及认知表现的影响。；Verified applicability）Tg4-42 · Verified applicability · 阿尔兹海默症 (AD) 模型（研究Aβ4-42相关的海马神经发生改变，以及活动条件对齿状回结构和神经元生成的影响。；Verified applicability）rTg4510 · Verified applicability · 阿尔兹海默症 (AD) 模型（研究 tau 病理、神经退变及 tau 表达抑制的阶段性影响；不适用于单独评价 Aβ 病理。；Verified applicability）